Active Biotech AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2016
Selling, General & Admin	12.36	13.17	13.94	15.06	15.25	Upgrade
Research & Development	25.24	26.67	32.54	42.82	34.54	Upgrade
Operating Expenses	37.6	39.84	46.48	57.89	49.78	Upgrade
Operating Income	-37.6	-39.84	-46.48	-57.89	-49.78	Upgrade
Interest Expense	-0.11	-0.18	-0.24	-0.21	-0.03	Upgrade
Interest & Investment Income	0.43	0.65	0.29	0.05	-	Upgrade
Currency Exchange Gain (Loss)	-0.04	-0.03	0.07	-0.01	0.02	Upgrade
EBT Excluding Unusual Items	-37.32	-39.4	-46.37	-58.05	-49.79	Upgrade
Gain (Loss) on Sale of Investments	-	-	0.57	-0.32	-0.03	Upgrade
Pretax Income	-37.32	-39.4	-45.8	-58.37	-49.83	Upgrade
Net Income	-37.32	-39.4	-45.8	-58.37	-49.83	Upgrade
Net Income to Common	-37.32	-39.4	-45.8	-58.37	-49.83	Upgrade
Shares Outstanding (Basic)	1,347	420	272	234	214	Upgrade
Shares Outstanding (Diluted)	1,347	420	272	234	214	Upgrade
Shares Change (YoY)	220.46%	54.84%	16.21%	9.23%	26.87%	Upgrade
EPS (Basic)	-0.03	-0.09	-0.17	-0.25	-0.23	Upgrade
EPS (Diluted)	-0.03	-0.09	-0.17	-0.25	-0.23	Upgrade
EBITDA	-36	-38.24	-44.78	-57.89	-48.48	Upgrade
D&A For EBITDA	1.6	1.6	1.7	0	1.3	Upgrade
EBIT	-37.6	-39.84	-46.48	-57.89	-49.78	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.